Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

224 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-17

Study Completion Date

2023-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter trial with randomized control and evaluator blind method, which meets the screening criteria total of 224 subjects were enrolled and randomly divided into control group and experiment according to 1:1 ratio Group), the subjects in the control group used medical ultrasonic coupler, and the subjects in the test group used test instruments Combined with medical ultrasonic coupler, use 5 days per week according to the prescribed use method (duration:Use the whole face for 10 minutes, use twice a day, a total of 20 minutes), continuous use 12Week. The changes of relevant clinical indicators and laboratory instrument measurements were evaluated.

Objective : To evaluate the efficacy of radiofRF in reducing skin wrinkles and treating loose skin after 12 weeks of use of the test product Effectiveness and safety of relaxation and firming of skin tissue.

The subjects were adults aged 18 years and above, regardless of gender, and had obvious wrinkles on the skin around the face and eyes (according to the selection Standard confirmation).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study on the Safety, Efficacy of Home RF Cosmetic Instrument in the Treatment of Facial or Periorbital Wrinkles（F-MFR300-RD-003）

NCT06565884

Skin Wrinkles

COMPLETED NA

Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles

NCT01795417

Periorbital Wrinkles

COMPLETED NA

Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device

NCT05096247

Wrinkle Benign Pigmented Lesions Benign Vascular Lesions

COMPLETED NA

Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles

NCT06657365

Facial Wrinkles Anti-Aging Wrinkles and Rhytides +2 more

COMPLETED NA

Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

NCT03776461

Rhytides Wrinkle

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the clinical trial was to see if home radiofrequency beauty devices were effective in treating adults for reducing skin wrinkles. It will also learn about the safety of home RF beauty devices. The main questions it aims to answer are:

1. Reduction of facial or periocular wrinkles based on Fitzpatrick score (12 weeks);
2. Possible adverse reactions and satisfaction survey during the use of subjects;

The researchers will compare the radiofrequency beauty device group with the control group (only medical ultrasonic coupling) to verify whether the home radiofrequency beauty device is effective in reducing skin wrinkles.

Participants will:

Receive home treatment according to the experimental group and continue to use it for 12 weeks.

At the 6th and 12th week, they will visit the medical institution for questionnaire survey and skin test.

Keep a diary of their symptoms and the number of times they use radiofrequency beauty device or medical ultrasonic coupling.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Wrinkles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The method of randomized control and evaluator blindness is suitable for screening A total of 224 subjects were enrolled and randomly divided into control group and experiment according to 1:1 ratio Group)

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Three doctors set up a blind evaluation group to evaluate the photos of the subjects before and after receiving the device treatment

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Home radiofrequency skin treatment instrument

Radiofrequency skin therapy instrument with medical ultrasound coupler is used for 20 minutes a day, 5 days a week

Group Type EXPERIMENTAL

Home radiofrequency skin treatment instrument

Intervention Type DEVICE

Subjects in the experimental group were treated with the test instrument combined with medical ultrasonic coupler for 5 days a week according to the prescribed use method (duration of use: 10 minutes for the whole face, continuous use twice a day, a total of 20 minutes) for 12 weeks. To evaluate the reduction of wrinkles before and after treatment and the changes of laboratory instruments.

Medical ultrasound coupler

Medical ultrasound coupler is applied to the face for 20 minutes a day, 5 days a week

Group Type PLACEBO_COMPARATOR

Ultrasonic coupler for medical purposes

Intervention Type OTHER

In control group, medical ultrasonic coupler was evenly applied on face and orbit for 5 days a week (duration: 20 minutes) for 12 consecutive days Week. To evaluate the reduction of wrinkles and the change of laboratory instruments before and after use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home radiofrequency skin treatment instrument

Subjects in the experimental group were treated with the test instrument combined with medical ultrasonic coupler for 5 days a week according to the prescribed use method (duration of use: 10 minutes for the whole face, continuous use twice a day, a total of 20 minutes) for 12 weeks. To evaluate the reduction of wrinkles before and after treatment and the changes of laboratory instruments.

Intervention Type DEVICE

Ultrasonic coupler for medical purposes

In control group, medical ultrasonic coupler was evenly applied on face and orbit for 5 days a week (duration: 20 minutes) for 12 consecutive days Week. To evaluate the reduction of wrinkles and the change of laboratory instruments before and after use.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (1) Adults aged 18 and above, male or female;
* (2) Fitzpatrick's wrinkles and elasticity scores around the face and eyes were 2-7 points (on-site assessment);
* (3) To avoid sun exposure during the test;
* (4) Be able to read Chinese and accurately understand, and sign the informed consent of the test;
* (5) can cooperate with and participate in the test return visit time, and timely reflect their own health status or any changes in drugs, adverse reaction symptoms;
* (6) Urine pregnancy reaction is negative (women of childbearing age).

Exclusion Criteria

* (1) Abnormal vital signs (blood pressure, pulse, body temperature), except for minor abnormalities that are not clinically significant as determined by the doctor;
* (2) There is a pacemaker or internal defibrillator in the body, or any other active electrical implant anywhere in the body;
* (3) The treatment area has permanent implants, such as metal plates and screws (e.g. dentures, metal teeth), silicone implants or injected chemicals;
* (4) There is or has been a history of skin cancer, or any other type of cancer, or malignant pre-nevus;
* (5) serious comorbidities, such as heart disease, epilepsy, high blood pressure and liver or kidney disease;
* (6) Plan to become pregnant or breastfeed during the study period, or less than 6 months after delivery;
* (7) Have a history of bleeding and clotting, or long-term use of anticoagulation and antiplatelet drugs (aspirin ≤81mg daily is not excluded);
* (8) Suffering from autoimmune diseases;
* (9) have an immunosuppressive disease such as AIDS, or an impaired immune system caused by the use of immunosuppressive drugs (investigators' judgment);
* (10) Subjects with a history of heat-stimulated disease, such as recurrent herpes simplex in the treatment area, should only be treated after a pre-prevention regimen;
* (11) Poor control of diseases related to the endocrine system as determined by the investigator, such as diabetes or thyroid dysfunction;
* (12) Any active condition in the treatment area identified by the investigator, such as ulcers, eczema, or other skin lesions;
* (13) A history of skin diseases, such as keloid, abnormal wound healing, psoriasis, etc.;
* (14) Any invasive or non-invasive treatment (such as hair removal, light rejuvenation, microneedles or chemical exfoliation, etc.) in the treated area within 3 months prior to treatment;
* (15) Received RF microneedle therapy, injection of fillers or botulinum toxin within 6 months prior to treatment;
* (16) Receive semi-permanent fillers (poly-l-lactic acid, calci-hydroxy-phospholite, etc.) within 24 months before treatment;
* (17) Have undergone facial medical or cosmetic surgery (e.g. eyelid/eyebrow surgery, periorbital or perioral soft tissue enhancement, permanent fillers, permanent makeup, tattoos, etc.);
* (18) Use of drugs that may trigger photosensitization during the study period (such as quinolones, aspirin, hyd rochlorothiazide or furosemide);
* (19) Use of any medications that affect skin characteristics (e.g., vitamin A, steroids, thyroid medications, etc.) in the past 6 months;
* (20) Participate in a clinical trial of another drug or device in which the last treatment of the investigational drug/device occurred 3 months before the start of treatment in the study;
* (21) Plan to change previously used skin care products during the study period;
* (22) Other conditions deemed unsuitable for inclusion by the researcher.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes